Rashmi Mabiyan
Principal Correspondent at The Economic Times
Principal Correspondent @EconomicTimes. Writes on #Health #Science #Technology
Articles
-
1 month ago |
flipboard.com | Rashmi Mabiyan
3 hours agoIn a grim reminder for students flocking abroad, and in particular the UK for higher education, an Indian PhD student has raised several concerns. Some of the red flags are the validity of one-year MSc courses, their global rankings, cost-of-living, and rampant racism, among others. The student, …
-
2 months ago |
flipboard.com | Rashmi Mabiyan
Children aged two among thousands of overweight Scottish youngsters referred for specialist help on the NHSThousands of overweight children in Scotland, including tots as young as two, have been referred for specialist help. Since 2020/21, more than 4,000 …
-
Oct 29, 2024 |
bhartiyamedia.com | Rashmi Mabiyan |Abhijeet Singh
By Rashmi Mabiyan and Abhijeet SinghNew Delhi: The never-ending demand for healthcare services bulked with the presumptions of favourable results, places immense pressure on the Indian industry still operating on traditional models and is expected to rise further, driven by the high disease burden in the country compounded with an expanding middle-aged population who are more prone to chronic health issues.
-
Oct 29, 2024 |
flipboard.com | Rashmi Mabiyan
Deficit of standardised data a roadblock to develop AI-based healthcare models in India: ExpertsBy Rashmi Mabiyan and Abhijeet Singh New Delhi: The never-ending demand for healthcare services bulked with the presumptions of favourable results, …
-
Oct 18, 2024 |
flipboard.com | Rashmi Mabiyan
Amd 7 is a trick to rob voters of their power. Vote no. Missouri may be the "Show Me" State, but the politicians who snuck the deceptive Amendment 7 onto this November's ballot aren't living up to our …
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 98
- Tweets
- 78
- DMs Open
- No
RT @ETPharma: Join Us for a Deep Dive into the Future of Indian Pharma! Date: 4th December 2024 Time: 12:00 PM onwards Live Webinar Regi…
Asia's 1st bloodless heart transplant patient shows remarkable postoperative recovery https://t.co/T9tBZTYLZp via @ETHealthWorld #Asia | #bloodless | #heart | #transplant | #healthnews
Breast Cancer Awareness Month: 'Targeted therapies have increased breast cancer cure rate to 60-70 per cent' #oncology | #breastcancer | #hormonalfactors | #cancer | #healthnews @HospitalsApollo https://t.co/N1QUk1GtaK via @ETHealthWorld